Chase Knickerbocker
Stock Analyst at Craig-Hallum
(3.41)
# 1,071
Out of 4,412 analysts
11
Total ratings
63.64%
Success rate
1.94%
Average return
Main Sectors:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INDV Indivior | Initiates: Buy | $37 | $17.58 | +110.47% | 1 | Apr 3, 2024 | |
| FENC Fennec Pharmaceuticals | Maintains: Buy | $17 → $18 | $9.21 | +95.44% | 2 | Mar 18, 2024 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $20 → $22 | $17.81 | +23.53% | 1 | Mar 5, 2024 | |
| ACST Acasti Pharma | Initiates: Buy | $6 | $2.81 | +113.52% | 1 | Feb 7, 2024 | |
| IRWD Ironwood Pharmaceuticals | Initiates: Buy | $21 | $7.82 | +168.54% | 1 | Jan 17, 2024 | |
| MDXG MiMedx Group | Initiates: Buy | $12 | $6.27 | +91.39% | 1 | Oct 27, 2023 | |
| SCPH scPharmaceuticals | Initiates: Buy | $20 | $4.49 | +345.43% | 1 | Sep 7, 2023 | |
| XTNT Xtant Medical Holdings | Maintains: Buy | $1 → $1.2 | $0.95 | +26.32% | 2 | Jul 11, 2023 | |
| PHAT Phathom Pharmaceuticals | Initiates: Buy | $21 | $9.18 | +128.76% | 1 | Mar 13, 2023 |
Indivior
Apr 3, 2024
Initiates: Buy
Price Target: $37
Current: $17.58
Upside: +110.47%
Fennec Pharmaceuticals
Mar 18, 2024
Maintains: Buy
Price Target: $17 → $18
Current: $9.21
Upside: +95.44%
Avadel Pharmaceuticals
Mar 5, 2024
Maintains: Buy
Price Target: $20 → $22
Current: $17.81
Upside: +23.53%
Acasti Pharma
Feb 7, 2024
Initiates: Buy
Price Target: $6
Current: $2.81
Upside: +113.52%
Ironwood Pharmaceuticals
Jan 17, 2024
Initiates: Buy
Price Target: $21
Current: $7.82
Upside: +168.54%
MiMedx Group
Oct 27, 2023
Initiates: Buy
Price Target: $12
Current: $6.27
Upside: +91.39%
scPharmaceuticals
Sep 7, 2023
Initiates: Buy
Price Target: $20
Current: $4.49
Upside: +345.43%
Xtant Medical Holdings
Jul 11, 2023
Maintains: Buy
Price Target: $1 → $1.2
Current: $0.95
Upside: +26.32%
Phathom Pharmaceuticals
Mar 13, 2023
Initiates: Buy
Price Target: $21
Current: $9.18
Upside: +128.76%